death domain fadd antibody Search Results


death domain fadd  (Boster Bio)
91
Boster Bio death domain fadd
Death Domain Fadd, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/death+domain+fadd+antibody/pm30671458-92-15-20?v=Boster+Bio
Average 91 stars, based on 1 article reviews
death domain fadd - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier
fadd  (Boster Bio)
90
Boster Bio fadd
Fig. 2. Scutellarein treatment activated the intrinsic apoptosis pathway in multiple myeloma cells in vitro. A–C, analysis <t>of</t> <t>caspase-9,</t> -8 and -3 activities in IM-9, MM.1R or viable circulating B lymphocytes (CBL) after treatment with indicated concentrations of scutellarein for 24 h. Caspase activity was measured by the relative fluorescent units (RFU) of cleaved substrates. Data was normalized to the vehicle-treated CBL group. D–I, influence of <t>FADD</t> or APAF1 knockdown on the apoptosis- inducing effect of 400 μg/ml scutellarein treatment for 24 h. shRNA targeting green fluorescent protein gene (sh-NC) was used as negative control for FADD or APAF1 knockdown. Data in DeI were normalized to the un-transfected group (WT) in each cell line. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
Fadd, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/death+domain+fadd+antibody/pm30551468-69-3-5?v=Boster+Bio
Average 90 stars, based on 1 article reviews
fadd - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
fas‑associated death domain  (Beijing Solarbio Science)
90
Beijing Solarbio Science fas‑associated death domain
Fig. 2. Scutellarein treatment activated the intrinsic apoptosis pathway in multiple myeloma cells in vitro. A–C, analysis <t>of</t> <t>caspase-9,</t> -8 and -3 activities in IM-9, MM.1R or viable circulating B lymphocytes (CBL) after treatment with indicated concentrations of scutellarein for 24 h. Caspase activity was measured by the relative fluorescent units (RFU) of cleaved substrates. Data was normalized to the vehicle-treated CBL group. D–I, influence of <t>FADD</t> or APAF1 knockdown on the apoptosis- inducing effect of 400 μg/ml scutellarein treatment for 24 h. shRNA targeting green fluorescent protein gene (sh-NC) was used as negative control for FADD or APAF1 knockdown. Data in DeI were normalized to the un-transfected group (WT) in each cell line. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
Fas‑Associated Death Domain, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/death+domain+fadd+antibody/pm35782905-98-2-10?v=Beijing+Solarbio+Science
Average 90 stars, based on 1 article reviews
fas‑associated death domain - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
antibodies toward fas-associated death domain protein (fadd)  (MBL Life science)
90
MBL Life science antibodies toward fas-associated death domain protein (fadd)
Fig. 2. Scutellarein treatment activated the intrinsic apoptosis pathway in multiple myeloma cells in vitro. A–C, analysis <t>of</t> <t>caspase-9,</t> -8 and -3 activities in IM-9, MM.1R or viable circulating B lymphocytes (CBL) after treatment with indicated concentrations of scutellarein for 24 h. Caspase activity was measured by the relative fluorescent units (RFU) of cleaved substrates. Data was normalized to the vehicle-treated CBL group. D–I, influence of <t>FADD</t> or APAF1 knockdown on the apoptosis- inducing effect of 400 μg/ml scutellarein treatment for 24 h. shRNA targeting green fluorescent protein gene (sh-NC) was used as negative control for FADD or APAF1 knockdown. Data in DeI were normalized to the un-transfected group (WT) in each cell line. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
Antibodies Toward Fas Associated Death Domain Protein (Fadd), supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/death+domain+fadd+antibody/10__3892_slash_ijmm__15__5__833-30-3-22?v=MBL+Life+science
Average 90 stars, based on 1 article reviews
antibodies toward fas-associated death domain protein (fadd) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
fas associating death domain containing protein fadd antibody  (Abbexa)
N/A
Polyclonal Antibody to Fas Associating Death Domain Containing Protein FADD
   Buy from Supplier

Image Search Results


Fig. 2. Scutellarein treatment activated the intrinsic apoptosis pathway in multiple myeloma cells in vitro. A–C, analysis of caspase-9, -8 and -3 activities in IM-9, MM.1R or viable circulating B lymphocytes (CBL) after treatment with indicated concentrations of scutellarein for 24 h. Caspase activity was measured by the relative fluorescent units (RFU) of cleaved substrates. Data was normalized to the vehicle-treated CBL group. D–I, influence of FADD or APAF1 knockdown on the apoptosis- inducing effect of 400 μg/ml scutellarein treatment for 24 h. shRNA targeting green fluorescent protein gene (sh-NC) was used as negative control for FADD or APAF1 knockdown. Data in DeI were normalized to the un-transfected group (WT) in each cell line. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Scutellarein selectively targets multiple myeloma cells by increasing mitochondrial superoxide production and activating intrinsic apoptosis pathway.

doi: 10.1016/j.biopha.2018.09.024

Figure Lengend Snippet: Fig. 2. Scutellarein treatment activated the intrinsic apoptosis pathway in multiple myeloma cells in vitro. A–C, analysis of caspase-9, -8 and -3 activities in IM-9, MM.1R or viable circulating B lymphocytes (CBL) after treatment with indicated concentrations of scutellarein for 24 h. Caspase activity was measured by the relative fluorescent units (RFU) of cleaved substrates. Data was normalized to the vehicle-treated CBL group. D–I, influence of FADD or APAF1 knockdown on the apoptosis- inducing effect of 400 μg/ml scutellarein treatment for 24 h. shRNA targeting green fluorescent protein gene (sh-NC) was used as negative control for FADD or APAF1 knockdown. Data in DeI were normalized to the un-transfected group (WT) in each cell line. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.

Article Snippet: Antibodies for detecting FADD (PA1464, BosterBio, Pleasanton, USA), Apaf-1 (PA1249-1, BosterBio), active Caspase-3 (269518, Novus Biologicals, Littleton, USA) Bax (AF820, R& D Systems, Minneapolis, USA), Bcl-2 (RP1003, BosterBio) and GAPDH (HPA040067, Atlas Antibodies, Bromma, Sweden) were applied following manufacturer’s instructions.

Techniques: In Vitro, Activity Assay, Knockdown, shRNA, Negative Control, Transfection